Co-Authors
This is a "connection" page, showing publications co-authored by Daniele Giacobbe and Matteo Bassetti.
Connection Strength
13.803
-
Use of Ceftaroline in Hospitalized Patients with and without COVID-19: A Descriptive Cross-Sectional Study. Antibiotics (Basel). 2021 Jun 23; 10(7).
Score: 0.952
-
Antiviral treatment selection for SARS-CoV-2 pneumonia. Expert Rev Respir Med. 2021 08; 15(8):985-992.
Score: 0.946
-
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study. J Clin Med. 2021 Feb 03; 10(4).
Score: 0.927
-
The COVID-19 insidious trick: Subjective perception of numbers. Eur J Clin Invest. 2021 02; 51(2):e13465.
Score: 0.917
-
Bloodstream infections in critically ill patients with COVID-19. Eur J Clin Invest. 2020 Oct; 50(10):e13319.
Score: 0.897
-
COVID-19: Some clinical questions after the first 4 months. Eur J Clin Invest. 2020 Jul; 50(7):e13326.
Score: 0.891
-
A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic. Drugs Context. 2020; 9.
Score: 0.884
-
The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm. Eur J Clin Invest. 2020 Mar; 50(3):e13209.
Score: 0.866
-
Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy. Core Evid. 2019; 14:31-40.
Score: 0.831
-
The safety of treatment options for acute bacterial skin and skin structure infections. Expert Opin Drug Saf. 2019 08; 18(8):635-650.
Score: 0.827
-
Treatment of Infections Due to MDR Gram-Negative Bacteria. Front Med (Lausanne). 2019; 6:74.
Score: 0.818
-
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP). Infect Dis Ther. 2021 Dec; 10(4):1837-1885.
Score: 0.240
-
The role of PCSK9 in infectious diseases. Curr Med Chem. 2021 Jul 14.
Score: 0.239
-
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy. BMC Infect Dis. 2021 Apr 15; 21(1):353.
Score: 0.235
-
Spread of Carbapenem-Resistant Gram-Negatives and Candida auris during the COVID-19 Pandemic in Critically Ill Patients: One Step Back in Antimicrobial Stewardship? Microorganisms. 2021 Jan 03; 9(1).
Score: 0.230
-
Higher Mortality and Intensive Care Unit Admissions in COVID-19 Patients with Liver Enzyme Elevations. Microorganisms. 2020 Dec 16; 8(12).
Score: 0.230
-
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors. J Clin Med. 2020 Aug 27; 9(9).
Score: 0.225
-
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia. PLoS One. 2020; 15(8):e0237831.
Score: 0.225
-
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection. Eur J Clin Invest. 2020 Oct; 50(10):e13358.
Score: 0.224
-
Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP). Clin Microbiol Infect. 2020 Jul; 26(7):880-894.
Score: 0.220
-
Challenges and research priorities to progress the impact of antimicrobial stewardship. Drugs Context. 2019; 8:212600.
Score: 0.210
-
Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project. Mycoses. 2019 Apr; 62(4):310-319.
Score: 0.201
-
Ceftolozane/tazobactam: place in therapy. Expert Rev Anti Infect Ther. 2018 04; 16(4):307-320.
Score: 0.190
-
Management of KPC-producing Klebsiella pneumoniae infections. Clin Microbiol Infect. 2018 Feb; 24(2):133-144.
Score: 0.183
-
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology. Clin Microbiol Infect. 2021 Aug 26.
Score: 0.060
-
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study. Crit Care. 2021 06 21; 25(1):214.
Score: 0.060
-
Tracheostomy Timing and Outcome in Severe COVID-19: The WeanTrach Multicenter Study. J Clin Med. 2021 Jun 16; 10(12).
Score: 0.059
-
Early Effects of Passive Leg-Raising Test, Fluid Challenge, and Norepinephrine on Cerebral Autoregulation and Oxygenation in COVID-19 Critically Ill Patients. Front Neurol. 2021; 12:674466.
Score: 0.059
-
The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome. Front Med (Lausanne). 2021; 8:671714.
Score: 0.059
-
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity. PLoS Pathog. 2021 04; 17(4):e1009448.
Score: 0.059
-
Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study. Crit Care. 2021 03 19; 25(1):111.
Score: 0.058
-
Computed tomography assessment of PEEP-induced alveolar recruitment in patients with severe COVID-19 pneumonia. Crit Care. 2021 02 24; 25(1):81.
Score: 0.058
-
Molecular Epidemiological Investigation of a Nosocomial Cluster of C. auris: Evidence of Recent Emergence in Italy and Ease of Transmission during the COVID-19 Pandemic. J Fungi (Basel). 2021 Feb 15; 7(2).
Score: 0.058
-
Systemic fibrinolysis for acute pulmonary embolism complicating acute respiratory distress syndrome in severe COVID-19: a case series. Eur Heart J Cardiovasc Pharmacother. 2021 01 16; 7(1):78-80.
Score: 0.058
-
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study. Infect Dis Ther. 2021 Mar; 10(1):387-398.
Score: 0.058
-
Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review. J Clin Med. 2021 Jan 03; 10(1).
Score: 0.058
-
Neurological Complications and Noninvasive Multimodal Neuromonitoring in Critically Ill Mechanically Ventilated COVID-19 Patients. Front Neurol. 2020; 11:602114.
Score: 0.057
-
Is a step-down antiretroviral therapy necessary to fight severe acute respiratory syndrome coronavirus 2 in HIV-infected patients? AIDS. 2020 10 01; 34(12):1865-1867.
Score: 0.057
-
Chest physiotherapy: An important adjuvant in critically ill mechanically ventilated patients with COVID-19. Respir Physiol Neurobiol. 2020 11; 282:103529.
Score: 0.056
-
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy. Clin Microbiol Infect. 2020 Nov; 26(11):1537-1544.
Score: 0.056
-
Neurological Manifestations of Severe SARS-CoV-2 Infection: Potential Mechanisms and Implications of Individualized Mechanical Ventilation Settings. Front Neurol. 2020; 11:845.
Score: 0.056
-
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020 Aug; 46(8):1524-1535.
Score: 0.056
-
Distinct phenotypes require distinct respiratory management strategies in severe COVID-19. Respir Physiol Neurobiol. 2020 08; 279:103455.
Score: 0.055
-
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study. J Infect. 2019 08; 79(2):130-138.
Score: 0.052
-
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection. Int J Antimicrob Agents. 2018 Feb; 51(2):244-248.
Score: 0.046